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A Study of Complicated Falciparum Malaria and Efﬁcacy
of Arteether in Children in Endemic Area of India
M.L. Sharma
WHO NPSP India, Bikaner, India
Malaria has re-emerged as main public health problems.
In tropical countries resulting in signiﬁcant morbidity and
mortality. Plasmodium falciparum is responsible for poten-
tially fatal infections.
Aims and Objectives:
(1) To evaluate the efﬁcacy of Arteether in the treatment
of complicated malaria
(2) To analyze clinical spectrum of hospitalized cases of
falciparum and virex malaria.
Material and Methods: The study at Urban Private
Hospital Patients with pyrexia and slides positive for P.
falciparum. Out of 75 patients 24 were children with com-
plicated malaria. A dose of Arteether (2.5mg/Kg.) once
daily by intra-muscular injection for 3 consecutive days,
patients remained hospitalised,the therapeutic response
was assessed on clinical parameter and smears for parasites.
Results: Out of 75 smear positive 24 children of com-
plicated malaria. 1 to 17 year age, clinical symptoms
fever, hyperpyrexia 100%, vomiting 40%, headache 15%,
icterus 35%, alerted sensorium 25%, oligourea 10%, bleed-
ing 5% weakness, bodyache, loss of appetite,insomnia.
Splenomegaly and hepatomegaly > 2 cm in 82% and 78%.
serum bilirubin > 3mg% and elevated SGOT, SGPT > 3
times, serum cretanin > 3mg% and blood urea > 40mg%
renal failure. Severe anaemia Hb < 5mg%. Complicated
falciparum malaria with jaundice and hepatic dysfunc-
tion.33.3%,cerebral malaria 25%, renal failure 13.3%,
haemoglobinria 0.4%, severe anemia with symptomic
involvement 33.3%.
The therapuetic response was assessed on clinical param-
eters and smears for parasites. Level of consciousness
started improving with in 24—48 hours and full consciousness
48 to 72 hour Fever clearance 24 to 48 hours. Serum bilirubin
levels start decreasing 3 days normal within 7-days. Serum
creatinine normal within 7 days Anemia in children with
arteether patient responded well. Splenomegaly regressed
in one month, parasitic clearance with arteether within 2
days, in 22 patients four week 92% of cure rate in compli-
cated P. falciparum malaria.
doi:10.1016/j.ijid.2008.05.830
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Background: Malaria is a major global health prob-
lem with high mortality rates especially in children below
ﬁve years of age. A severe limitation of chemotherapy is
the rapid emergence of resistance to most available anti-
malarials. Because of the slow development of new effective
anti-malarials, an alternative strategy is therapy optimiza-
tion using existing drugs. Combination therapy has been
shown to delay the onset of resistance and improve the
efﬁcacy of treatment. This study’s objective was to estab-
lish the activity of several cyclic Adenosine Monophosphate
(cAMP) modulators as potential components of combination
therapy.
Methods: The cAMP modulators; forskolin, Sp-adenosine
3′ 5 cyclic monophosphorothiate triethylammonium salt, 9-
cyclopentyladenine and 2′ 5′ dideoxyadenosine 3′ monophos-
phate were tested in vitro in combination with chloroquine,
quinine, meﬂoquine, amodiaquine and doxycycline against
the chloroquine sensitive strain (D6) and the chloroquine
resistant strain (W2) of Plasmodium falciparum. Parasite sus-
ceptibility testing was performed using a semi-automated
micro-dilution technique. The Inhibitory Concentration at
50% (IC50) was calculated for each drug and in ﬁxed com-
binations. Isobolograms were plotted using the calculated
Fractional Inhibitory Concentration at 50% (FIC50).
Results: One of the AC-inhibitors, in combination with
quinine showed synergistic interactions at all concentration
ratios for both the D6 and W2 strains (FIC50s < 0.92 at all
concentrations). The other anti-malarial/cAMP modulator
combinations demonstrated a range of responses but mainly
exhibited antagonistic interactions.
Conclusion: These in vitro ﬁndings suggest that the AC
inhibitor, 2′ 5′ dideoxyadenosine 3′ monophosphate, poten-
tially enhanced the anti-malarial activity when combined
with quinine and should be further evaluated. The other
anti-malarial/cAMP Modulator combinations did not show
the same potential.
doi:10.1016/j.ijid.2008.05.831
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Backgroud: Malaria is an important cause of mor-
bidity,however not everyone infected with the parasite
develops clinical symptoms. Naturally acquired immunity to
malaria varies considerably between geographical regions
due to different parasite strains and transmission intensi-
ties which affect the selection of vaccine targets. Merozoite
surface protein 3 (MSP3) is a polymorphic antigen induces
immune response. This study measured the presence of anti-
bodies to P. falciparum MSP3 recombinant antigen in plasma
from asymptomatic individuals in relation to protection from
malaria during the transmission season.
Methods: The study was conducted in an area of seasonal
transmission on a cohort of 114 asymptomatic sub-patent P.
falciparum carriers who were examined for the presence
of IgG, IgG1 and IgG3 by ELISA. The cohort was treated
